Ex- Viropharma linkedin page
Pharmaceutical Manufacturing • 
Exton, Pennsylvania, United States • 51-100 Employees
Company overview
| Headquarters | Exton, Pennsylvania, United States |
| Phone number | +16104587300 |
| Websites | |
| NAICS | 3254 |
| Employees | 51-100 |
| Socials |
Key Contacts at Ex- Viropharma linkedin page
Vianney Moreau
General Manager France Belgium Holland And Senior Director Sales Force Effectiveness Europe
Robert Doody
Assistant Director, Investor Relations
Charles Preston
Senior Director, Clinical Opeations
Jian Xi
Director, Commercial Analysis
Marc Uknis
Medical Director
Rob Bigham
Corporate Account Director
Vinnie Milano
Ceo
John Watson
Director, Regulatory Affairs, Europe
Mary Schumacher
Director, Medical Writing
Mary Schumacher
Director, Medical Writing
Ex- Viropharma linkedin page Email Formats
Ex- Viropharma linkedin page uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 48.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 24.1% |
{first name}@company.com | john@company.com | 12.4% |
{last name}.{first name}@company.com | doe.john@company.com | 8.9% |
{first name}{last name}@company.com | johndoe@company.com | 6.4% |
About Ex- Viropharma linkedin page
Retired from Pharmaceutical Industry
Ex- Viropharma linkedin page revenue & valuation
| Annual revenue | $6,929,955 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $22,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Ex- Viropharma linkedin page has 45 employees across 10 departments.
Departments
Number of employees
Germany
China
Belgium
Frequently asked questions
4.8
40,000 users
